Opdivo + Yervoy receives FDA approval for new indication in melanoma

Bristol-Myers Squibb’s Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Expanded FDA Appr [...]

Keytruda approved for expanded indication

FDA Approves Expanded Indication for Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patient [...]

It is the mission of the Midwest Melanoma Partnership to facilitate the sharing of ideas, clinical trials and resources in an effort to improve the diagnosis, treatment and long-term care of melanoma patients.

Useful Links

Here you will find additional information from other organizations that may help you during a melanoma diagnosis or search for additional information about melanoma.

Read more

Support Our Mission

The work of the Midwest Melanoma Partnership is made possible through our sponsors and charitable giving of our donors.

Read more

Patient Stories

Meet Pat- Pat is a 5 year survivor of melanoma.

Read more

Clinical Trials

Clinical trials are research studies that involve people. They are the final step in a long process that begins with laboratory research and testing in animals. Many treatments used today are the result of past clinical trials

Read more

Midwest Melanoma Partnership Corporate Sponsors